
Research keeps asking a question that matters to many families: how do the immune system and brain interact in autism? Research published in 2026 examines cytokines, microglia and different immune profiles. These studies are relevant to our wider conversations about children’s health, alongside—not interchangeable with—research on PANS/PANDAS.
The big study, by the numbers
A review published online in Molecular Psychiatry on May 28, 2026 combined findings from:
- 98 studies.
- 54 cytokines.
- 4,236 autistic participants.
- 3,333 non-autistic comparison participants.
- Ages 2–65: this was not a study of children alone.
What are cytokines?
Cytokines are signaling proteins that help immune cells communicate. Immune signaling also interacts with the nervous system.
The meta-analysis found higher group-level concentrations of several cytokines, including:
- IL-1β and IL-4.
- IL-6 and IL-8.
- IFN-γ and TNF-α.
These are comparisons between groups, not a diagnostic result for an individual child. The study did not establish a clear relationship between cytokine concentrations and variation in autism traits within the autistic group. Its findings support closer investigation of immune biology.
Microglia: immune cells in the nervous system
The research on microglia and autism examines these cells and their relationship with autism. Microglia help:
- Monitor the brain’s environment.
- Respond to injury or infection signals.
- Clear damaged material.
- Regulate immune activity and participate in shaping connections between neurons.
Researchers are studying how these functions differ across biological contexts. A related 2026 neuroinflammation review explores inflammatory pathways and potential treatment targets. Much of the mechanistic work involves laboratory or animal models, which is different from showing a treatment works in children.
Six proposed immune profiles
A Journal of Neuroimmunology scoping review proposes a research framework with six groupings:
- Immune overactivation.
- Immune deficiency.
- Autoimmunity-related patterns.
- Gut–immune axis dysregulation.
- Post-infectious or immune-triggered onset patterns.
- Maternal immune activation.
These are proposed research categories, not an established clinical classification. The central idea is that one immune pattern may not describe everyone on the autism spectrum.
What immune differences could mean for care
Three areas of health are closely connected: immunity, the brain and autism. Understanding differences could help researchers ask better questions and, eventually, develop more individualized care.
For parents, the useful step is to bring specific health concerns to a clinician. Our immune-evaluation questions and gut–brain research article explore related conversations. We can follow the science closely while continuing to ask for thoughtful care for each child.
